This study conducts a narrative review to summarize evidence regarding changes of peripheral IGF-1 in MDD patients and assess a marker and predictive role of the parameters for emotional and cognitive disturbances, and treatment effectiveness. Here, IGF1 is linked to major depressive disorder.